Biotechnology

A Turkish man who opened his supposed biological father's grave has found the remains of a woman, according to DNA results cited by local media. 

Beer is one of the oldest and most popular American beverages around.  Just about anyone who has consumed any kind of alcohol has probably at the very least tasted beer.  It is one of the most inexpensive yet loved alcoholic beverages in the industry.  Beer comes in hundreds of varieties and flavors, combinations and levels of alcohol contents.  While it is very popular in all areas of the worl

The head of the Greek police's crime lab is calling on the relatives of missing people from the east Attica wildfires to provide DNA samples so that forensic investigators can complete the process of identifying dozens of victims.

A World Cup-fueled boon for beer sales is not faring well for thirsty drinkers in Russia and the U.K.

First, celebrations of Sweden's victory over South Korea sucked Nizhny Novgorod, Russia dry. Now, Moscow bars and restuarants are running low on beer supply, too.

Andreas Lykourentzos, a former health minister who was named in a prosecutor's report as one of 10 politicians who had allegedly received kickbacks from Swiss pharma giant Novartis, has written to Parliament Speaker Nikos Voutsis asking for the creation of a special committee to examine the charges against him.

The long-running saga of a parliamentary investigation into a bribery scandal involving the Swiss drugs manufacturer Novartis will enter its final phase on Friday, as the House will meet to discuss and vote on the final committee report.

Takeda Pharma agreed to buy London-listed Shire for 45.3 billion pounds ($61.50 billion) on May 8 after the Japanese company raised the amount of cash in its offer to $30.33 to secure a recommendation.

Lawmakers will debate in a plenary session on May 18 the results of a report completed by an inquiry committee into the alleged bribery of Greek politicians by the Swiss drugs firm Novartis.

Following a series of heated sessions, during which opposition MPs walked off the panel, the committee concluded on April 26 that it is not competent to examine the case.

Swiss pharmaceuticals giant Novartis announced on April 9 it will buy U.S. gene therapy company AveXis for $8.7 billion (7.1 billion euros).

Swiss pharmaceuticals giant Novartis announced on March 27 it will sell its stake in its consumer healthcare joint venture to Britain's GlaxoSmithKline for $13 billion (10.4 billion euros).